BMEA
Price
$2.10
Change
+$0.06 (+2.93%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
121.99M
39 days until earnings call
TCRX
Price
$1.84
Change
+$0.06 (+3.37%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
101.01M
40 days until earnings call
Interact to see
Advertisement

BMEA vs TCRX

Header iconBMEA vs TCRX Comparison
Open Charts BMEA vs TCRXBanner chart's image
Biomea Fusion
Price$2.10
Change+$0.06 (+2.93%)
Volume$16.21K
Capitalization121.99M
TScan Therapeutics
Price$1.84
Change+$0.06 (+3.37%)
Volume$7.34K
Capitalization101.01M
BMEA vs TCRX Comparison Chart in %
Loading...
BMEA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMEA vs. TCRX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMEA is a StrongBuy and TCRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (BMEA: $2.11 vs. TCRX: $1.84)
Brand notoriety: BMEA and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMEA: 59% vs. TCRX: 62%
Market capitalization -- BMEA: $121.99M vs. TCRX: $101.01M
BMEA [@Biotechnology] is valued at $121.99M. TCRX’s [@Biotechnology] market capitalization is $101.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMEA’s FA Score shows that 0 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • BMEA’s FA Score: 0 green, 5 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, both BMEA and TCRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMEA’s TA Score shows that 5 TA indicator(s) are bullish while TCRX’s TA Score has 3 bullish TA indicator(s).

  • BMEA’s TA Score: 5 bullish, 4 bearish.
  • TCRX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BMEA is a better buy in the short-term than TCRX.

Price Growth

BMEA (@Biotechnology) experienced а +7.95% price change this week, while TCRX (@Biotechnology) price change was +2.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

BMEA is expected to report earnings on Nov 04, 2025.

TCRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMEA($122M) has a higher market cap than TCRX($101M). TCRX YTD gains are higher at: -39.474 vs. BMEA (-47.165). BMEA has higher annual earnings (EBITDA): -113.26M vs. TCRX (-130.55M). TCRX has more cash in the bank: 218M vs. BMEA (56.2M). BMEA has less debt than TCRX: BMEA (7.05M) vs TCRX (96.7M). TCRX has higher revenues than BMEA: TCRX (6.96M) vs BMEA (0).
BMEATCRXBMEA / TCRX
Capitalization122M101M121%
EBITDA-113.26M-130.55M87%
Gain YTD-47.165-39.474119%
P/E RatioN/AN/A-
Revenue06.96M-
Total Cash56.2M218M26%
Total Debt7.05M96.7M7%
TECHNICAL ANALYSIS
Technical Analysis
BMEATCRX
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 23 days ago
90%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
BMEA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTRAF66.63N/A
N/A
Metro, Inc.
IMXCF1.00N/A
N/A
IMAX China Hldg Inc
NWVCF0.28N/A
N/A
EnWave Corp.
NRSDY16.75N/A
N/A
NORDIC SEMICONDUCTOR ASA
PREM0.03N/A
N/A
Premier Air Charter Holdings Inc.

BMEA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMEA has been loosely correlated with TCRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if BMEA jumps, then TCRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMEA
1D Price
Change %
BMEA100%
-0.49%
TCRX - BMEA
38%
Loosely correlated
-3.26%
CAI - BMEA
38%
Loosely correlated
-2.33%
ZLDAF - BMEA
37%
Loosely correlated
N/A
IDYA - BMEA
37%
Loosely correlated
+0.08%
MLTX - BMEA
37%
Loosely correlated
+4.51%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with MGNX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then MGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
+3.37%
MGNX - TCRX
46%
Loosely correlated
+4.85%
FATE - TCRX
44%
Loosely correlated
+2.39%
CRBU - TCRX
41%
Loosely correlated
+10.36%
RGNX - TCRX
40%
Loosely correlated
+3.10%
STRO - TCRX
40%
Loosely correlated
+2.32%
More